Literature DB >> 3300275

Cholecystokinin receptor antagonists: a review.

M A Silverman, R E Greenberg, S Bank.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3300275

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  7 in total

1.  Comparative molecular field analysis of CCK-A antagonists using field-fit as an alignment technique. A convenient guide to design new CCK-A ligands.

Authors:  S Rault; R Bureau; J C Pilo; M Robba
Journal:  J Comput Aided Mol Des       Date:  1992-12       Impact factor: 3.686

2.  Feline cholescintigraphy. Studies on role of cholecystokinin in regulation of gallbladder function.

Authors:  T Niewiarowski; A H Maurer; R S Fisher; B Krevsky
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

3.  Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.

Authors:  C Scarpignato; G Varga; I Dobronyi; M Papp
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

4.  Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats.

Authors:  I Imoto; M Yamamoto; D M Jia; M Otsuki
Journal:  Int J Pancreatol       Date:  1997-12

5.  Inhibitory effects of the cholecystokinin antagonist loxiglumide on pancreatic exocrine secretion and pancreatic growth in conscious rats.

Authors:  S Taguchi; G M Green; I Nakano; Y Hatta
Journal:  Int J Pancreatol       Date:  1992-04

Review 6.  Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.

Authors:  D Perilli; C Mansi; V Savarino; G Celle
Journal:  Int J Pancreatol       Date:  1993-06

Review 7.  Neurobiological investigations into the role of cholecystokinin in panic disorder.

Authors:  J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.